Clinical, biochemical, and molecular characterization of patients with glutathione synthetase deficiency

Citation
E. Al-jishi et al., Clinical, biochemical, and molecular characterization of patients with glutathione synthetase deficiency, CLIN GENET, 55(6), 1999, pp. 444-449
Citations number
20
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Molecular Biology & Genetics
Journal title
CLINICAL GENETICS
ISSN journal
00099163 → ACNP
Volume
55
Issue
6
Year of publication
1999
Pages
444 - 449
Database
ISI
SICI code
0009-9163(199906)55:6<444:CBAMCO>2.0.ZU;2-Q
Abstract
Pyroglutamic aciduria (5-oxoprolinuria) is a rare autosomal recessive disor der caused by either glutathione synthetase deficiency (GSSD) or 5-oxoproli nase deficiency. GSSD results in low glutathione levels in erythrocytes and may present with hemolytic anemia alone or together with pyroglutamic acid uria, metabolic acidosis, and CNS damage. Five patients with pyroglutamic a ciduria were studied. All presented with hemolytic anemia and metabolic aci dosis. Two (brothers) also had Fanconi nephropathy, which is not seen in py roglutamic aciduria. Molecular analyses of the GSS gene was performed in 3 patients. RT-PCR and heteroduplex analysis identified a homozygous deletion in 1 patient and a homozygous mutation in 2 others (brothers with Fanconi nephropathy). Sequencing of glutathione synthetase (GSS) cDNA from the firs t patient showed a 141-bp deletion corresponding to the entire exon 4, whil st the corresponding genomic DNA showed a G(491) --> A homozygous splice si te mutation. Sequencing of GSS cDNA from the Fanconi nephropathy patients s howed a C-847 --> T [ARG(283) --> CYS] mutation in exon 9.